Cargando…
Is BCG vaccination causally related to reduced COVID‐19 mortality?
The ongoing severe acute respiratory sickness coronavirus 2 (SARS‐CoV‐2) pandemic has resulted in more than 3,600,000 detected cases of COVID‐19 illness and nearly 260,000 deaths worldwide as of May 6, 2020. Recently, BCG vaccination was shown to correlate with reduced COVID‐19 case fatality rates (...
Autor principal: | Miyasaka, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267326/ https://www.ncbi.nlm.nih.gov/pubmed/32379923 http://dx.doi.org/10.15252/emmm.202012661 |
Ejemplares similares
-
BCG vaccine: Worrying proposal for COVID-19
por: Sarinho, Emanuel, et al.
Publicado: (2021) -
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
por: Koti, Madhuri, et al.
Publicado: (2020) -
Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2020) -
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 – what’s old is new again?
por: O'Connor, Ellen, et al.
Publicado: (2020) -
Considering BCG vaccination to reduce the impact of COVID-19
por: Curtis, Nigel, et al.
Publicado: (2020)